NO20013416D0 - Polyhydroksypyrazinderivater, deres fremstilling samt preparater inneholdende derivatene - Google Patents

Polyhydroksypyrazinderivater, deres fremstilling samt preparater inneholdende derivatene

Info

Publication number
NO20013416D0
NO20013416D0 NO20013416A NO20013416A NO20013416D0 NO 20013416 D0 NO20013416 D0 NO 20013416D0 NO 20013416 A NO20013416 A NO 20013416A NO 20013416 A NO20013416 A NO 20013416A NO 20013416 D0 NO20013416 D0 NO 20013416D0
Authority
NO
Norway
Prior art keywords
derivatives
choh
cor
preparation
stereoisomeric forms
Prior art date
Application number
NO20013416A
Other languages
English (en)
Other versions
NO20013416L (no
NO320398B1 (no
Inventor
Herve Bouchard
Alain Commercon
Original Assignee
Aventis Pharma Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Sa filed Critical Aventis Pharma Sa
Publication of NO20013416D0 publication Critical patent/NO20013416D0/no
Publication of NO20013416L publication Critical patent/NO20013416L/no
Publication of NO320398B1 publication Critical patent/NO320398B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
    • C07D241/10—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D241/12—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/12—Ophthalmic agents for cataracts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Neurology (AREA)
  • Hematology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Ophthalmology & Optometry (AREA)
  • Neurosurgery (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Vascular Medicine (AREA)
  • Child & Adolescent Psychology (AREA)
  • Pain & Pain Management (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
NO20013416A 1999-01-11 2001-07-10 Polyhydroksypyrazinderivater, deres fremstilling,medikamenter inneholdende disse samt deres anvendelse for fremstilling av et medikament. NO320398B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9900186A FR2788274B1 (fr) 1999-01-11 1999-01-11 Nouveaux derives de polyhydroxypyrazines, leur preparation et les compositions pharmaceutiques qui les contiennent
PCT/FR2000/000026 WO2000042027A1 (fr) 1999-01-11 2000-01-07 Nouveaux derives de polyhydroxypyrazines, leur preparation et les compositions pharmaceutiques qui les contiennent

Publications (3)

Publication Number Publication Date
NO20013416D0 true NO20013416D0 (no) 2001-07-10
NO20013416L NO20013416L (no) 2001-09-06
NO320398B1 NO320398B1 (no) 2005-11-28

Family

ID=9540746

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20013416A NO320398B1 (no) 1999-01-11 2001-07-10 Polyhydroksypyrazinderivater, deres fremstilling,medikamenter inneholdende disse samt deres anvendelse for fremstilling av et medikament.

Country Status (24)

Country Link
US (1) US6818637B2 (no)
EP (1) EP1140861B1 (no)
JP (1) JP4516694B2 (no)
KR (1) KR100648324B1 (no)
CN (1) CN1145615C (no)
AT (1) ATE244226T1 (no)
AU (1) AU774627B2 (no)
BR (1) BR0007449B1 (no)
CA (1) CA2359463C (no)
CZ (1) CZ301380B6 (no)
DE (1) DE60003631T2 (no)
DK (1) DK1140861T3 (no)
EA (1) EA003550B1 (no)
ES (1) ES2198273T3 (no)
FR (1) FR2788274B1 (no)
HU (1) HU228761B1 (no)
IL (2) IL143945A0 (no)
NO (1) NO320398B1 (no)
NZ (1) NZ512911A (no)
PL (1) PL200682B1 (no)
PT (1) PT1140861E (no)
SK (1) SK286389B6 (no)
WO (1) WO2000042027A1 (no)
ZA (1) ZA200105657B (no)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN100425596C (zh) * 2006-03-29 2008-10-15 中国烟草总公司郑州烟草研究院 脱氧果糖嗪的制备方法
CN101697972B (zh) * 2009-11-16 2011-08-10 朱峰 新曲霉酸在制备抗肿瘤药物中的应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2238081A1 (en) * 1995-11-22 1997-05-29 S. Jane Desolms Inhibitors of farnesyl-protein transferase
FR2744365B1 (fr) * 1996-02-06 1998-02-27 Inst Malgache Rech Appl Melanges isolables a partir de graines d'eugenia jambolana lamarck, leur preparation et l'utilisation de ces melanges et certains de leurs constituants comme medicaments
FR2766185B1 (fr) * 1997-07-18 2001-06-15 Rhone Poulenc Rorer Sa Medicaments contenant en tant que principe actif au moins un derive substitue de polyhydroxylalkylpyrazines, les nouveaux derives polyhydroxylalkylpyrazines et leur preparation

Also Published As

Publication number Publication date
EA003550B1 (ru) 2003-06-26
FR2788274A1 (fr) 2000-07-13
SK9762001A3 (en) 2001-12-03
CA2359463C (fr) 2009-09-15
EP1140861A1 (fr) 2001-10-10
CN1352638A (zh) 2002-06-05
DK1140861T3 (da) 2003-10-20
NO20013416L (no) 2001-09-06
FR2788274B1 (fr) 2001-02-09
SK286389B6 (sk) 2008-09-05
IL143945A (en) 2006-04-10
JP2002534513A (ja) 2002-10-15
JP4516694B2 (ja) 2010-08-04
NZ512911A (en) 2003-10-31
HU228761B1 (en) 2013-05-28
CZ20012483A3 (cs) 2001-10-17
KR100648324B1 (ko) 2006-11-23
PT1140861E (pt) 2003-11-28
DE60003631T2 (de) 2004-06-03
US6818637B2 (en) 2004-11-16
EP1140861B1 (fr) 2003-07-02
HUP0105104A3 (en) 2002-09-30
WO2000042027A1 (fr) 2000-07-20
ES2198273T3 (es) 2004-02-01
EA200100767A1 (ru) 2001-12-24
IL143945A0 (en) 2002-04-21
KR20010101456A (ko) 2001-11-14
PL200682B1 (pl) 2009-01-30
PL348768A1 (en) 2002-06-03
CA2359463A1 (fr) 2000-07-20
BR0007449A (pt) 2001-10-16
DE60003631D1 (de) 2003-08-07
CN1145615C (zh) 2004-04-14
HUP0105104A2 (hu) 2002-07-29
AU774627B2 (en) 2004-07-01
BR0007449B1 (pt) 2011-08-09
ZA200105657B (en) 2002-10-10
NO320398B1 (no) 2005-11-28
AU3051500A (en) 2000-08-01
US20020077324A1 (en) 2002-06-20
CZ301380B6 (cs) 2010-02-03
ATE244226T1 (de) 2003-07-15

Similar Documents

Publication Publication Date Title
LU91210I2 (fr) Emodepside & Praziquantel ainsi que leurs dérivés pharmaceutiqement acceptables (PROFENDER)
ATE180257T1 (de) Pyrazolderivate
MX9205542A (es) Compuesto heterociclico nitrogenado.
BG104853A (en) Thienylazolylalcoxyethanamines, their preparation and their application as medicaments
ATE271045T1 (de) Sauerstoffhaltige heterocyclische verbindungen
AR036000A1 (es) Proceso para la preparacion de derivados de indol y novedosos intermediarios
NO20013416D0 (no) Polyhydroksypyrazinderivater, deres fremstilling samt preparater inneholdende derivatene
AU5840686A (en) Improvements in or relating to pyrazoles
BR0001744A (pt) Processo para a preparação de 2-alquila-3-aminotiofeno útil como um fungicida agrìcola ou seu intermediário
AU576926B2 (en) Tetrazole derivatives
FI843264A (fi) Foerfarande foer framstaellning av antimikrobiella bensoesyraderivat.
DE69426620T2 (de) Antidepressiva
GB917078A (en) Improvements in or relating to piperidine derivatives
FI932188A0 (fi) Oktahydronaftalenoximderivat foer inhibering av kolesterolbiosyntesen, deras framstaellning och anvaendning
NO980994L (no) Substituerte fosfinsyreforbindelser og deres anvendelse som farmas÷ytika
ATE144900T1 (de) Verwendung von xanthinderivaten gegen magengeschwüre
TR200001437T2 (tr) Nörokinin muhasımlar olarak eşdeğer edilen oksimler.
ES352528A1 (es) Procedimiento de obtencion de composiciones herbicidas parael desherbaje de los arrozales.
DK0998464T3 (da) Polyhydroxyalkylpyrazinderivater, deres fremstilling samt medikamenter indeholdende disse forbindelser
GB938646A (en) New piperazine derivatives
NO932002L (no) Nye tiosemikarbazonsyreestere
TH2445A (th) ไพริมิดีนที่ถูกแทนที่
NO20010244D0 (no) Medikamenter inneholdende polyhydroksyalkylpyrazinderivater, deres fremstilling samt medikamenter inneholdende derivatene
ES2150073T3 (es) Nuevos agentes fungicidas ll-15g256gamma, delta y epsilon, producidos por el ll-15g256 (hypoxylon oceanicum).
TH13791A (th) อนุพันธ์ต่างๆของกรดบิวไทริค

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees